Jeffrey Lieberman

Jeffrey Alan Lieberman (born 1948) is an American psychiatrist who specializes in schizophrenia and related psychoses and their associated neuroscience (biology) and pharmacological treatment (psychiatric drugs). He was principal investigator for CATIE, the largest and longest independent study ever funded by the United States National Institute of Mental Health to examine existing pharmacotherapies for schizophrenia.[2] He was president of the American Psychiatric Association from May 2013 to May 2014.[3]

Jeffrey A. Lieberman
Born1948 (age 73–74)
CitizenshipAmerican
Alma materMiami University (B.S.)
George Washington University Medical School (M.D.)
Saint Vincent's Catholic Medical Center
Known forSchizophrenia research, NIMH CATIE study[1]
Children2
AwardsLieber Prize for Schizophrenia Research from the National Association for Research in Schizophrenia and Affective Disorders; the Adolph Meyer Award from the American Psychiatric Association; the Research Award from the National Alliance on Mental Illness, and the Neuroscience Award from the International College of Neuropsychopharmacology
Scientific career
FieldsPsychiatry
InstitutionsAmerican Psychiatric Association, Columbia University Vagelos College of Physicians and Surgeons, New York State Psychiatric Institute, University of North Carolina School of Medicine, Mount Sinai School of Medicine, Albert Einstein College of Medicine, Zucker Hillside Hospital of Long Island Jewish Medical Center

Education

Lieberman graduated from Miami University in 1970, and then received his medical degree from the George Washington School of Medicine in 1975. He completed his postgraduate training in psychiatry at St. Vincent's Hospital and Medical Center of New York Medical College.

Career

Lieberman is the Lawrence E. Kolb Professor of Psychiatry at the Columbia University Vagelos College of Physicians and Surgeons, where he directs the Lieber Center for Schizophrenia Research in the Department of Psychiatry at Columbia. He is a member of the National Academy of Sciences and was president of the American Psychiatric Association in 2013-2014. He has written 700 journal articles and a dozen books.

For 17 years (2005-2022), Lieberman was Chair of the Department of Psychiatry at the Columbia University Vagelos College of Physicians and Surgeons and the psychiatrist-in-chief of New York-Presbyterian Hospital/Columbia University Irving Medical Center[4]

In February 2022, Lieberman commented on Twitter about a posting concerning Nyakim Gatwech, a South Sudanese model; his one-sentence tweet was condemned as having racist and sexist overtones. A day later, he was relieved of his responsibilities as department chair and the hospital's chief of psychiatry and suspended from his faculty position at Columbia. [5]

Administration

Lieberman is or has been a member of the advisory committee for Neuropharmacologic and Psychopharmacologic Drugs of the Food and Drug Administration, the Planning Board for the Surgeon General's Report on Mental Health, the Committee on Research on Psychiatric Treatments of the APA, the APA Work Group for the Development of Schizophrenia Treatment Guidelines, the Brain Disorders and Clinical Neuroscience Review Committee, the National Advisory Mental Health Council of the NIMH, and currently chairs the APA Council of Research..

Research

Lieberman's research has focused on the neurobiology, pharmacology and treatment of schizophrenia and related psychotic disorders. His work has focused on understanding the natural history and pathophysiology of schizophrenia and the pharmacology and clinical effectiveness of antipsychotic drugs.

His research has been supported by grants from the National Institutes of Health and the NARSAD, Stanley, and Mental Illness Foundations.

CATIE study

Lieberman served as principal investigator for Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) sponsored by the National Institute of Mental Health (NIMH).[1] The investigators compared a "first-generation antipsychotic, perphenazine, with several newer drugs in a double-blind study".[6] "Probably the biggest surprise of all was that the older medication produced about as good an effect as the newer medications, three of them anyway, and did not produce neurological side effects at greater rates than any of the other drugs," Lieberman told The New York Times.[7]

Journals edited

Lieberman serves, or has served, as associate editor of the American Journal of Psychiatry, Biological Psychiatry, Neuropsychopharmacology, Acta Psychiatrica Scandinavica, Schizophrenia Research, NeuroImage, The International Journal of Neuropsychopharmacology, and Schizophrenia Bulletin.

Publications

Lieberman's work has been published in around 700 articles in the scientific literature. He has edited or co-edited 17 books, including the textbook Psychiatry (currently in its second edition), Textbook of Schizophrenia, Comprehensive Care of Schizophrenia, Psychiatric Drugs and Ethics in Psychiatric Research: A Resource Manual on Human Subjects Protection.[4]

In 2015, he published the book Shrinks: the Untold Story of Psychiatry (Little Brown). A four-part series, tentatively titled "In Search of Madness: The Untold Story of Mental Illness," based on his book, Shrinks, is scheduled for broadcast on PBS in April 2022.

A book on schizophrenia is scheduled to be published by Scribner in 2022.

Awards and honors

Lieberman is a member of the National Academy of Sciences Institute of Medicine and a fellow of the American Association for the Advancement of Science (AAAS).

He received the Lieber Prize for Schizophrenia Research from NARSAD,[8] the Adolph Meyer Award from the American Psychiatric Association (APA),[9] the Stanley R. Dean Award for Schizophrenia Research from the American College of Psychiatrists,[10] the APA Research Award , the APA Kempf Award for Research in Psychobiology , the APA Gralnick Award for Schizophrenia Research , the Ziskind-Somerfeld Award of the Society of Biological Psychiatry , the Ernest Strecker Award of the University of Pennsylvania , the Lilly Neuroscience Award from the Collegium Internationale Neuro-Psychopharmacologicum for Clinical Research , the Scientific Research Award,[11] the Exemplary Psychiatrist Award from the National Alliance on Mental Illness , the Ed Hornick Memorial Award of The New York Academy of Medicine,[12] and the Strecker Award of the Department of Psychiatry at the University of Pennsylvania.[13]

Reception and controversy

Journalist Robert Whitaker wrote about potentially human rights-violating experiments he led in a Boston Globe series,[14] for which Lieberman described Whitaker as a "menace to society."[15][16]

A review of Lieberman's 2015 book Shrinks in The Guardian criticized the book for focusing almost entirely on American psychiatry, for its "triumphalist" narrative, and for failing to discuss Lieberman's financial relationship with pharmaceutical companies.[17]

During the presidency of Donald Trump, Lieberman cited the American Psychiatric Association's Goldwater rule to become a critic[18][19][20] of psychiatrists such as Robert Jay Lifton, Judith Lewis Herman, and Bandy X. Lee, who warned against what they termed "the president's dangerousness".[21] Lieberman wrote an article in Vice discussing the former President’s mental state,[22] which some described as violating the Goldwater rule in a favorable way to Trump.[23] Some saw this as linked to funding increases for Lieberman’s research and organizations during that time.[24]

In February 2022, Lieberman was criticized by colleagues and students for calling Nyakim Gatwech, a Sudanese American model, a "freak of nature."[25][26][27][28] He subsequently deleted his Twitter account.[29] According to the New York Times, Lieberman's tweet had said "Whether a work of art or freak of nature she's a beautiful sight to behold."[30] The New York State Office of Mental Health (OMH) asked for his resignation as Director of the New York State Psychiatric Institute, and as of February 22nd, Lieberman was no longer affiliated with OMH or the State of New York.[31] Lieberman was suspended as Chair of the Department of Psychiatry at Columbia University and removed from his position as Psychiatrist-in-Chief at NewYork-Presbyterian/Columbia University Irving Medical Center (NYP/CUIMC) on February 23rd, 2022.[30] Some pointed to his actions as representing years of unaddressed racist and sexist behavior.[31][32][33][34]

John McWhorter, a colleague at Columbia, defended Lieberman in a New York Times op-ed decrying cancel culture in general, and in particular the failure of a single voice at Columbia to consider "an isolated Tweet" against a person's entire life and work.[35]

Personal life

Lieberman resides in New York City[4] with his wife, Rosemarie,[36] and two sons.[37]

Notes
  1. "Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE)". National Institute of Mental Health. 2005–2008. Archived from the original on May 26, 2013. Retrieved May 26, 2013.
  2. "Questions and Answers About the NIMH Clinical Antipsychotic Trials of Intervention Effectiveness Study (CATIE) — Phase 1 Results". National Institute of Mental Health, U.S. Department of Health and Human Services. September 2005. Archived from the original on May 26, 2013. Retrieved May 28, 2013.
  3. "Jeffrey A. Lieberman". Columbia University. Retrieved May 26, 2013.
  4. "Jeffrey Lieberman, M.D." Columbia University Department of Psychiatry. 2005–2008. Retrieved May 26, 2013.
  5. "Jeffrey Lieberman Suspended from Academic and Clinical roles following racist tweet". Columbia Spectator. Retrieved February 24, 2022.
  6. Lieberman, Jeffrey A.; et al. (September 22, 2005). "Effectiveness of Antipsychotic Drugs in Patients with Chronic Schizophrenia". The New England Journal of Medicine. Massachusetts Medical Society. 353 (12): 1209–1223. doi:10.1056/NEJMoa051688. PMID 16172203.
  7. Carey, Benedict (September 20, 2005). "Little Difference Found in Schizophrenia Drugs". The New York Times. Retrieved May 30, 2013.
  8. "Prestigious Lieber Prize for Research Awarded to Jeffrey A. Lieberman, M.D". National Institute of Mental Health. October 12, 2006. Archived from the original on April 27, 2013. Retrieved May 26, 2013.
  9. "Jeffrey Lieberman Receives Adolf Meyer Award From American Psychiatric Association". Columbia University Irving Medical Center. 2007-06-19. Retrieved 2022-02-23.
  10. "Dean Award Nominations and Past Winners". The American College of Psychiatrists. Archived from the original on 2022-02-23. Retrieved 2022-02-23.
  11. "Reception and Presentation of the 2011 NAMI Scientific Research Award". National Alliance on Mental Illness. Archived from the original on October 3, 2013. Retrieved May 26, 2013.
  12. "Jeffrey A. Lieberman Receives Hornick Award; Delivers Lecture on Early Interventions for Schizophrenia". The New York Academy of Medicine. January 12, 2012. Retrieved May 26, 2013.
  13. "Previous Strecker Award Recipients". The Trustees of the University of Pennsylvania. Retrieved May 26, 2013.
  14. "Boston Globe Online / Doing harm: Research on the mentally ill". psychrights.org. Retrieved 2022-02-28.
  15. "Listener mail - Dr. Jeffrey Lieberman". Retrieved 2022-02-28.
  16. "Who's the Real "Menace to Society"? Journalist or Leading Psychiatrist?". CounterPunch.org. 2015-05-29. Retrieved 2022-02-28.
  17. "Shrinks: The Untold Story of Psychiatry by Jeffrey Lieberman – review". the Guardian. 2015-04-05. Retrieved 2021-04-04.
  18. Lieberman, Jeffrey (2017-11-15). "The Dangerous Case of Psychiatrists Writing About the POTUS's Mental Health". Psychiatric News. 52 (22). doi:10.1176/appi.pn.2017.11b13.
  19. "The Dangers of Speculating About Trump's Mental Health". Medscape. Retrieved 2021-04-17.
  20. Lieberman, Jeffrey A. (2018-02-01). "Psychiatrists Diagnosing the President — Moral Imperative or Ethical Violation?". New England Journal of Medicine. 378 (5): 483–484. doi:10.1056/NEJMc1716751. ISSN 0028-4793. PMID 29281477.
  21. "The Dangerous Case of Donald Trump". Macmillan. Retrieved 2021-04-17.
  22. "These Experts Think Trump May Actually Have Dementia". www.vice.com. Retrieved 2021-04-17.
  23. Dr. B; Lee (2021-02-22). "[COMMENTARY] Trumpism Did Not End With Donald Trump". HillReporter.com. Retrieved 2021-04-17.
  24. Kendall, Joshua (2020-04-25). "Muzzled by Psychiatry in a Time of Crisis". Mad In America. Retrieved 2021-04-04.
  25. @columbia_wc4bl (23 February 2022). "Columbia WC4BL Statement on Jeffrey Lieberman". Retrieved 28 February 2022 – via Instagram.
  26. Jack Turban, MD [@jack_turban] (2022-02-21). "The chair of Columbia psychiatry called a woman a 'freak of nature,' referencing the color of her skin. There will be no consequences. He will continue to make the hiring decisions (including for faculty candidates who are women of color). Welcome to academic medicine" (Tweet). Archived from the original on 2022-02-22. Retrieved 2022-02-22 – via Twitter.
  27. Arghavan Salles, MD, PhD [@arghavan_salles] (2022-02-21). "A department chair at one of the top medical schools in this country thought it appropriate to call someone a freak of nature. That someone is a Black woman, not a 'freak,' and his post demonstrates the continued unconscionable dehumanization of Black people. This is racism" (Tweet). Archived from the original on 2022-02-22. Retrieved 2022-02-22 – via Twitter.{{cite web}}: CS1 maint: multiple names: authors list (link)
  28. orionnebula54 (2022-02-22). "I'm at a loss for words. This is Columbia's Chair of Psychiatry". r/premed. Retrieved 2022-02-22.
  29. Changa, Anoa (2022-02-22). "Columbia University Psychiatry Department Chair Jeffrey Lieberman Deletes His Account After Backlash For Racist Comment About Black Model". NewsOne. Archived from the original on 2022-02-23. Retrieved 2022-02-23.
  30. Fadulu, Lola (2022-02-23). "Columbia Psychiatry Chair Suspended After Tweet About Dark-Skinned Model". The New York Times. ISSN 0362-4331. Archived from the original on 2022-02-24. Retrieved 2022-02-25.
  31. Velasquez, Josefa (2022-02-24). "A Racist Tweet by Columbia Psychiatry Chair Ripples Through New York's Elite Medical Circles". THE CITY. Archived from the original on 2022-02-25. Retrieved 2022-02-25.
  32. Lee, Bandy X. (2022-03-01). "… The Harder They Fall". Medium. Retrieved 2022-03-05.
  33. Hart, Carl. "Want to eradicate racism and sexism? Define them first". nydailynews.com. Retrieved 2022-03-05.
  34. Watson, Elwood. "The 'freak of nature' problem". Johnson City Press. Retrieved 2022-03-05.
  35. McWhorter, John (2022-03-01). "Opinion | One Graceless Tweet Doesn't Warrant Cancellation". The New York Times. ISSN 0362-4331. Retrieved 2022-03-04.
  36. "Rainbow Light Home". Blessed Herbs. Archived from the original on 2016-12-21. Retrieved 2016-12-14.
  37. "Jeffrey Lieberman, M.D." clintara.com. Archived from the original on 2016-06-24. Retrieved 2016-12-14.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.